Inhaled Insulin in Development


By: J. Chanslor

Bristol-Myers Squibb and QDose have announced a collaboration to develop inhaled insulin.

QDose is now involved in early work on this new form of insulin.

Bristol-Myers Squibb will obtain worldwide exclusive rights to the product and, with skupport from QDose, will take the lead in development, manufacturing and commercialization of the licensed product.

-Bristol-Myers Squibb news release, September 2003



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.